RxDoctor Payments Data

Emanuel Warrington Colon, MD

Gastroenterology · Caguas, PRNPI 1629262456

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.5%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 80.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $2,493 and has fallen 95.0% since, to $125 in 2025.

$4,151in general payments, 2019–2025

Across 34 payments — averaging $122.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • E.r. Squibb & Sons, L.L.C.$294
  • Medtronic$200
  • Merck$170
  • Boston Scientific$99
  • Gilead$52

What the payments were for

  • Consulting fees$2,13851%
  • Food & beverage$2,00648%
  • Education$70%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie22$3,336
E.r. Squibb & Sons, L.L.C.6$294
Medtronic1$200
Merck2$170
Boston Scientific1$99
Gilead2$52

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,151 in reported general payments places this provider in the 70th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$5,900
Medicare patients
11
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$80,367
Sucralfate149$10,161
SuprepSodium, Potassium,mag Sulfates71$8,388
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates64$5,120
Pantoprazole Sodium608$4,284
Famotidine604$3,335
Dexlansoprazole DrDexlansoprazole14$3,069
Omeprazole181$970
Clarithromycin24$817
Midazolam HclMidazolam Hcl/Pf304$809
Fentanyl CitrateFentanyl Citrate/Pf162$548
Midazolam Hcl207$526
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl21$514
Amoxicillin26$432
Dicyclomine Hcl17$250

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Caguas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →